Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). - Wikidata - awgldk - TriplyDB

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

http://www.wikidata.org/entity/Q34312881

about

Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids Pathogenic potential of novel Chlamydiae and diagnostic approaches to infections due to these obligate intracellular bacteria Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniae Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodies Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections.Qualitative and quantitative detection of Chlamydophila pneumoniae DNA in cerebrospinal fluid from multiple sclerosis patients and controls.Trophoblast infection with Chlamydia pneumoniae and adverse pregnancy outcomes associated with placental dysfunction.Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers.Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Histopathologic diagnosis of fungal infections in the 21st century Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae.Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial.Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis.Undressing of Waddlia chondrophila to enrich its outer membrane proteins to develop a new species-specific ELISA.Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one en Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls.Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae Treatment of Chlamydia pneumoniae infection and chronic obstructive pulmonary disease.Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.Comparative Seroepidemiologic Analysis of Chlamydophila Pneumoniae Infection using Microimmunofluorescence, Enzyme Immunoassay and Neutralization Test: Implications for Serodiagnosis.Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.Chlamydia pneumoniae infections in asthma: clinical implications.Comparison of real-time PCR and a microimmunofluorescence serological assay for detection of chlamydophila pneumoniae infection in an outbreak investigation.Chlamydia infection status, genotype, and age-related macular degeneration.Serological cross-reactivity between different Chlamydia-like organisms.Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested How recent advances in molecular tests could impact the diagnosis of pneumonia.Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.Molecular genetic methods in the diagnosis of lower respiratory tract infections.Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children.

P2860

Q21563468-DBBBBF88-3EAF-44AA-A864-9F0FEC757302 Q24531865-5176EFB4-DB4C-4172-A508-C02678ED623E Q24545825-09B1FD0C-A0D0-48A2-B298-4ACEF12046D0 Q24798213-9C656F8D-1F61-443E-9A25-134387766CB2 Q26859186-1C2C85F9-44DF-45CE-B278-9031F4E4C0CE Q33355197-0B429F54-0E5A-4A97-8F55-B2B92EEC009B Q33392388-60BB86BC-5D6D-403F-9376-D962BA8755CF Q33428579-B555E733-3C83-487A-A4F8-70D43FB7F83C Q33431609-FE34A4EC-C200-4BBF-9351-169A8C644F4C Q33674644-1B5FB256-E046-4A0C-BE58-6E600DE433C4 Q33711781-1C9DD6F4-7D07-497A-A28F-ED34A9F34981 Q33752851-27D82E88-5738-4AE8-AE0A-E92F0A13ACC7 Q33788646-780CF8B4-8F2F-40A6-B491-57953E3D637E Q33868769-552AC1CB-5759-4D8A-AF95-75861BB7426E Q33885153-AD30451D-F938-4592-BAF0-4E171A614E56 Q33905858-0D8F34EE-CE1B-4D49-BDBB-AFDE6A6ADC8D Q33916075-54A0553B-F986-4AB8-B1D1-D52312FA16F1 Q33943276-32FE3C9A-354D-4F30-931B-1FBDC034FEFC Q34007328-E9A6673E-97E8-4959-9950-0BA3C17E5DF4 Q34174788-B0CEDFE4-33C2-4D66-8D42-4AC2CAE97E35 Q34286628-CEDE09F5-9987-4118-9623-50EDF65CDA03 Q34579483-47086ECA-29AE-4F59-9AC8-3F58C2780D3E Q34601757-96E073E1-22FE-40C0-9614-579604F6C250 Q34752011-8876BB6E-67D0-415F-A32A-D6454A0E9179 Q34781808-BCEB699C-3691-4F76-B008-998FB8B5BF7F Q34946766-936DEAFE-A75E-430A-829D-47E6A2F47796 Q34974820-BDFDFE50-8487-489F-B220-55BF2C5A938C Q35523803-6E93BEE4-F9D1-4C72-96AE-C19D1238ADEB Q35533027-63FF2376-44A1-48F3-944E-2C753F8926F1 Q35535328-F3D1DD87-7CAA-4B41-A03E-3D5CBDE865D1 Q35627745-B139DD0F-6E3E-4E40-B569-DF45566AB1C6 Q35668226-233D8F39-4758-4898-814F-7F1A25F1D409 Q35673398-FAA99AD2-1098-4117-ADDD-9150507DFED8 Q35690259-885103A4-2DA9-4BC9-9DA0-099A59F899D2 Q35758705-9E0DC2AC-EA25-478E-BA02-FB5E3AA13BC4 Q35821202-F9E8C18B-9B9F-43C4-97E3-F905CB102DE3 Q35927614-FA8473C0-22DD-4DB5-A965-0259501F2EF0 Q36000970-DF70D3C5-245D-4648-B960-E1B4491C7150 Q36003045-5DA9A880-24C9-4A0F-89C5-8505E303684C Q36022938-6C5467D0-0362-4A68-8144-84206831FCA6

P2860

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

http://www.wikidata.org/entity/Q34312881

description

2001 nî lūn-bûn

@nan

2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@ast

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@en

Standardizing Chlamydia pneumo ...... Disease Control and Prevention

@nl

type

label

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@ast

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@en

Standardizing Chlamydia pneumo ...... Disease Control and Prevention

@nl

prefLabel

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@ast

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@en

Standardizing Chlamydia pneumo ...... Disease Control and Prevention

@nl

P1433

Q34312881-E21468E1-F8BE-4228-83B1-0AB43E4B316B

P1476

Q34312881-6A37DC87-914C-4A15-9B15-1BD0A0C6A2F8

P2093

Q34312881-04A765B0-44AA-474C-A157-2F997CC8ADA8

Q34312881-15F0FC8E-4728-4FD6-B222-4F6AABB98C40

Q34312881-2A503B3A-E484-40CB-93A7-4D6E211B9A76

Q34312881-3CEFE4D8-F24D-403A-8B6F-F349641CD92A

Q34312881-62F717DB-21C2-4430-BE72-DDF3663C8F93

Q34312881-84FC5D98-C672-47CA-A8A2-5FA17C91360F

Q34312881-9F9511FF-D3C5-4FEF-B51D-4F2790044333

Q34312881-A1387468-3624-4145-9698-B355D56C86CF

Q34312881-A36EFFF3-E187-4497-92A8-0C8C66A6B425

Q34312881-ABA67358-A0CC-479C-9828-EB5078EC7EC7

P304

Q34312881-4E718542-1557-4584-A7AB-1FC151E5C52E

P31

Q34312881-E487BB87-1CDE-4D7F-A23D-9F77BF90FB77

P356

Q34312881-6D212DA2-1088-43F5-AC32-A795E20A28C1

P407

Q34312881-47D92CB2-8140-4863-B9E4-D05A3F192539

P433

Q34312881-23210E0D-B7F9-4941-BE50-693042B9F662

P478

Q34312881-C7A64B61-B036-4ECC-B66B-34512D95DF46

P577

Q34312881-B36B44FA-9981-4E2F-908A-6F8D358DB8A8

P5875

Q34312881-F8EC4090-0CAF-4124-AF64-934A602B13E9

P698

Q34312881-77625514-0C44-42C7-9ED9-8049F7AAE0E2

P921

Q34312881-2A7123F1-9567-4F81-A1C6-702574A79FF4

P356

P1433

Clinical Infectious Diseases

P1476

Standardizing Chlamydia pneumo ...... for Disease Control (Canada).

@en

P2093

B S Fields

http://www.w3.org/2001/XMLSchema#string

C C Kuo

http://www.w3.org/2001/XMLSchema#string

C. pneumoniae Workshop Participants

http://www.w3.org/2001/XMLSchema#string

D F Talkington

http://www.w3.org/2001/XMLSchema#string

G M Carlone

http://www.w3.org/2001/XMLSchema#string

J Boman

http://www.w3.org/2001/XMLSchema#string

J Guarner

http://www.w3.org/2001/XMLSchema#string

L A Jackson

http://www.w3.org/2001/XMLSchema#string

M L Tondella

http://www.w3.org/2001/XMLSchema#string

M Maass

http://www.w3.org/2001/XMLSchema#string

P304

492-503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/322632

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11880269

http://www.w3.org/2001/XMLSchema#string

P698

11462186

http://www.w3.org/2001/XMLSchema#string

P921